NCT06062394Recruiting
Penn Medicine Healthy Heart
Reducing Atherosclerotic Cardiovascular Disease (ASCVD) Through a Comprehensive Heart Disease Prevention Program (HDPP)
Source: ClinicalTrials.gov · Last updated 12 Mar 2026
Brief summary (registry, in English)
To leverage access to patients across the primary care network, EPIC tools for identifying eligible patients, and the Way to Health platform to launch and enroll a program that will be evaluated in a clinical trial that is focused on changing patient behavior and powered to detect differences in improving blood pressure and cholesterol over 6 months for Penn Medicine patients in West/Southwest Philadelphia and Lancaster.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 1980 (estimated)
- First submitted
- 25 Sept 2023
- Start date
- 11 Mar 2024
- Primary completion date
- Dec 2026
- Lead sponsor
- University of Pennsylvania
- Diseases
- High blood pressure
- NCT number
- NCT06062394
What you commit to
- Study type: Interventional
- Planned participants: 1980
- From 11 Mar 2024 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients on PCSK9 inhibitors
Other illness
- Documented statin allergy/ or intolerance in the EMR
- Markedly shortened life expectancy including:
- metastatic cancer
- hospice
- End Stage Renal Disease
- Congestive Heart Failure
- Dementia
Other
- Pregnancy
- Breast feeding
- Is a non-English speaker requiring a translator
- Patients who do not have a cell phone
Who the study is looking for
- On the Penn Medicine Primary Care Service Line registry
- Last 2 Blood Pressure readings with Systolic Blood Pressure \>=140 from any outpatient encounter in the last 12 months AND
- ASCVD dx OR ASCVD risk score ≥10% OR Diabetes dx OR A1c ≥6.5 in last year OR Diabetes registry OR Last LDL ≥190 in past five years AND
- Not on a statinor PCSK9, Inclisiran OR on a Low-intensity/moderate-intensity statin) with LDL \>100
Age in the registry: 35 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Penn Medicine Coordinator of this site? Confirm its status | Philadelphia | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.